
A groundbreaking wine bar to close this summer because ‘continuing felt untenable'
Goin and Styne cited a range of factors in their decision to close the Brentwood location, including sustained financial damages from the 2025 fires, the 2024 entertainment industry strikes, the pandemic and high rent.
'At this point, with this confluence of circumstances, continuing felt untenable,' Goin and Styne told The Times in an email. 'We are heartbroken that our Brentwood era has come to an end — we are so grateful to the 16 years' worth of staff, customers, farmers, vendors, winemakers and others who fueled our experience and made it a true joy.'
A.O.C. in West Hollywood will remain open. The lauded California-cuisine restaurant and wine bar has helped proliferate elegant but casual, produce-driven small plates since its founding in 2002. Goin and Styne operated Tavern, another of their restaurants, in the Brentwood space until 2021 and opened a new, larger location of A.O.C. in that location the same year.
'If the two A.O.C.s share little in common physically, they are identical twins philosophically,' L.A. Times Food critic Bill Addison wrote in a 2021 review. 'The menu redoubles the communal, small-plates ethos that Goin and Styne led the charge to codify in Los Angeles. The bounty is Californian; the oomph of flavors draws on cuisines distinct to the many cultures that exist around the continents-spanning Mediterranean Sea.'
A.O.C. is open in Brentwood Monday and Tuesday from 5 to 9 p.m., Wednesday and Thursday from 11:30 a.m. to 9 p.m., Friday from 11:30 a.m. to 10 p.m., Saturday from 10 a.m. to 10 p.m. and Sunday from 10 a.m. to 9 p.m.
11648 San Vicente Blvd., Los Angeles, (310) 806-6464, aocwinebar.com
What started as a homespun operation and catering service is now a buzzing dining room and a growing center of Filipino culture in Silver Lake.
Manila Inasal began humbly in chef Natalia Moran's San Juan home kitchen, where she cooked to feed front line workers during the pandemic. After reconnecting with her longtime family friends — Elzar Dodjie Simon, his wife and children — they became business partners and formed an L.A. ghost kitchen and catering service for Filipino rice bowls and heaped trays full of the likes of lumpia, adobo and ube mochi brownies.
Fans became so ravenous that multiple guests drove hours for a taste, sometimes visiting from other states, only to find no physical space for dining. It was then, the Simon family told The Times, that they realized they needed to open a full restaurant.
At the team's brick-and-mortar space, located in a strip mall bordering Virgil Village, Moran and the Simons are serving even more modern spins onFilipino cuisine with an expanded menu and options such as salted duck egg Caesar salad, laing reimagined as dip with focaccia, inasal-marinated milkfish, crab tortang talong, pork belly lechon sisig, a deconstructed kare kare made with oxtail and macadamia nuts and jackfruit-and-tofu adobo.
The dishes are portioned and served family style, a nod to Filipino's community-focused culture. Moran is also developing a high-tea menu, as well as new specials.
'We wanted to bring Filipino ingenuity and modernity,' said operating chief Elisha Paul Simon, adding, 'We're just so proud of Filipino culture in a world where it's so diverse.'
'We want to be part of the diversity,' said Moran. 'There's lots of Thai restaurants and Japanese and Korean ones. We want to make sure Filipino food is somewhere there, too.'
Elzar Dodjie Simon, a songwriter and music producer, also built a small stage into the dining room, where guests can hear Filipino artists' live music on weekends. Manila Inasal is open Tuesday to Saturday from 11 a.m. to 10 p.m. and Sunday from 11 a.m. to 8 p.m.
240 Virgil Ave., Los Angeles, (909) 206-5568, manilainasal.com
One of the Westside's most popular new restaurants is serving rotisserie chickens, fresh pastas, a rainbow of seasonal vegetables and fruit-laced salads, budget-conscious cocktails and house-made gelati in a former Mar Vista market and corner store. Hospitality vet and L.A. native Jeremy Adler (who worked at Cobi's and Resy) wanted to reimagine the 1949-built Beethoven Market into a neighborhood restaurant where families and dates can comingle on a tree-dotted, bulb-lit patio or in the dim, constantly humming dining room that overlooks a semi-open kitchen.
To head that kitchen, Adler tapped executive chef Michael Leonard (formerly of Rustic Canyon, Bucato and Mother Wolf), who leans heavily on the Santa Monica Farmers Market to inform his menu. Leonard's dishes trend Italian with a California-produce bent, such as seared prawns with fresh salsa verde; pizzas that come topped with clams, heirloom-pork sausage, zucchini, Meyer lemon and beyond; salads bright with citrus or stone fruit; and pork collar with cherries and roasted cabbage. Cocktails, priced around $13, involve strawberry shrubs, thyme-infused aperitifs, vodka infused with olive oil and more.
It's Adler's first standalone restaurant and one he hopes will be a boon to the neighborhood. The restaurateur lives nearby and wants to build more community through services like a possible early reservation system for locals. Beethoven Market is open Sunday to Wednesday from 5 to 9 p.m. and Thursday to Saturday from 5 to 10 p.m., with brunch service to follow.
12904 Palms Blvd., Los Angeles, (323) 579-1391, beethovenmarket.com
Westlake Village's buzzy new food hall is already home to some of L.A.'s biggest names, including Mini Kabob and a pizza offshoot from the Cheese Store of Beverly Hills.
Now, one of the world's most famous musicians is joining the quick-service food lineup. Grammy Award-winning artist Questlove — born Ahmir Thompson — is perhaps best known for his work as a producer and as the Roots' drummer and co-frontman, but he's also a cookbook author and food aficionado.
Now he's launched Mixtape, a new chicken shack that specializes in tenders, ground-chicken burgers and fried chicken sandwiches, plus offering vegetarian options and sides such as black-eyed peas slaw and waffle fries. Guests order Mixtape items from a touch screen within Neighborly food hall, which allows for mixing and matching dishes across the food hall's stands. Mixtape is open Sunday to Thursday from 11 a.m. to 9 p.m. and Friday and Saturday from 11 a.m. to 9:30 p.m.
4000 E. Thousand Oaks Blvd., Westlake Village, beneighborly.com
Prolific chef Eyal Shani recently touched down in Los Angeles with the first of what he hopes will be multiple West Coast restaurants. With a menu involving fresh stuffed pita, blistered peppers and a signature whole baby cauliflower, Shani's quick-and-casual Middle Eastern restaurant Miznon can now be found in Grand Central Market in the former Sari Sari Store stall.
Shani founded his pita shop in Tel Aviv in 2011, then expanded the operation globally with outposts that include Tokyo, Paris, London, New York City and Las Vegas — where it's one of the best restaurants on or off the Strip. Shani, now with more than 40 restaurants under his hospitality group, riffs on his Moroccan and Iraqi Jewish heritage and modern classics with Miznon dishes such as lamb kebab pita with spicy green peppers and grilled tomato; chicken schnitzel with matbucha; mesabaha lima beans with hard-boiled egg and tomato seeds; steel-seared 'candy' brisket; cheeseburger pita sandwiches; and a fish-and-chips pita made with branzino, potatoes and vinegar. Miznon is open daily in Grand Central Market from 11 a.m to 9 p.m.
317 S. Broadway, Los Angeles, miznonusa.com

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Intel earnings, Paramount-Skydance deal, Tesla rises
Here are some of the stories Wall Street is watching on Friday, July 25. Shares of Intel (INTC) are falling after posting a Q2 loss, though revenue topped estimates. The FCC has approved the $8 billion merger between Paramount (PARA, PARAA) and Skydance. Tesla (TSLA) shares are rising on a Business Insider report that the company plans to launch its robotaxi service in San Francisco this weekend. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute. It's time for Yahoo! Finance's market minute. Stocks are higher today as the major averages look to close out a strong week of gains amid earnings and trade updates. The S&P 500 now closing out its 13th record high in Thursday's trading session. Meanwhile, Intel shares are falling today after the chipmaker said it would slash founder costs and its latest attempt to turn around its struggling business. Concerns about where that leaves Intel's chip business and manufacturing overshadowed by a better than expected earnings report. Plus, Paramount and Skydance's $8 billion deal has been approved by the FCC. The deal, which was announced more than a year ago, includes the CBS broadcast television network, Paramount Pictures, and the Nickelodeon channel. Paramount chair, Sherry Redstone, is set to depart the company's board once the Skydance merger is complete. And Tesla shares are on the rise today as the company is reported to launch its robo taxis in San Francisco this weekend. That's according to Insider. Unlike its Austin debut, the robo taxis will use safety drivers seated in the cars. And that's your Yahoo! Finance market minute. Scan the QR code below to track the best and worst performing stocks of the trading session. Related Videos Japan's 'novel' US investment deal faces 'a lot' of questions Palantir highs, Phillips 66 Q2 beat, Comcast's Versant spin-off Question of the day: Are we in a market bubble? What Volkswagen's $1.5B tariff hit means for US expansion Sign in to access your portfolio
Yahoo
12 minutes ago
- Yahoo
Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance
Edwards Lifesciences' (NYSE:EW) stock surged Friday following a strong second-quarter 2025 earnings report that saw the medical device innovator surpass revenue and earnings expectations, driven by significant growth across its heart valve therapies. The strong performance prompted the company to raise its full-year sales guidance, signaling renewed momentum in its core markets. The heart devices company reported sales of $1.53 billion on Thursday after hours, beating the consensus of $1.49 billion and within the management guidance of $1.45 billion-$1.53 billion. Sales grew 11.9% or 10.6% adjusted, with strength across all product groups. Edwards Lifesciences reported adjusted earnings of 67 cents, beating the consensus of 62 cents and the management guidance of 59-65 cents per company reported Transcatheter Aortic Valve Replacement (TAVR) sales of $1.1 billion, marking an increase of 8.9% (or 7.8% on a constant currency basis). The company said that TAVR growth for the quarter surpassed their expectations. Transcatheter Mitral and Tricuspid Therapies (TMTT) segments achieved second-quarter sales of $134.5 million, demonstrating a year-over-year growth of 61.9%, or more than 57.1% on a constant currency basis. In the Surgical segment, second-quarter global sales reached $267 million, an increase of 7.7% over the prior year, or 6.8% on a constant currency basis. Outlook 'We are pleased to report strong second quarter results that delivered double-digit sales growth. Based on our better-than-expected first half performance and the many catalysts across our portfolio, we are confident in our full-year outlook and are raising our sales and EPS guidance,' said Bernard Zovighian, CEO. Edwards Lifesciences raised its 2025 sales guidance from $5.70 billion-$6.10 billion to $5.90 billion-$6.10 billion compared to the consensus of $5.91 billion. The company affirms fiscal 2025 adjusted earnings guidance of $2.40-$2.50 per share compared to the consensus of $2.48. Edwards Lifesciences forecasts third-quarter adjusted earnings of 54-60 cents, compared to the consensus of 60 cents, and sales of $1.46 billion, $1.54 billion versus the consensus of $1.48 billion. View more earnings on EW The company is increasing its underlying growth rate guidance for TAVR to 6% to 7%, driven by strong performance, and its sales guidance range for TAVR to $4.3 billion to $4.5 billion. Sales guidance for TMTT and Surgical product groups remains unchanged. Analyst Insights: Goldman Sachs Goldman Sachs said Friday that the second quarter of 2025 marked a key turning point for the company and reinforced its belief that Edwards is on track to achieve steady double-digit revenue growth again. The firm noted that Edwards' core TAVR business is gaining momentum, even though the quarter only partially reflected the impact of the new asymptomatic indication and included just a small boost from Boston Scientific Corporation's (NYSE:BSX) planned market exit. This gives Goldman confidence that the business will operate at a stronger baseline. Analyst David Roman expects Edwards to get back to its previous strong performance over the next few years, with revenue growing over 10% and operating margins above 30%. With this kind of growth, Goldman Sachs believes the stock deserves a higher valuation, more than 30 times its earnings. The analyst maintains the Buy rating, raising the price forecast from $89 to $101. Other Analysts Several leading financial analysts re-evaluated their outlook on Edwards Lifesciences, with a general trend toward increased price forecasts. Baird has maintained a Neutral rating on the company, slightly increasing its price forecast from $78 to $79. Deutsche Bank, on the other hand, reiterates a Buy rating and has significantly raised its price forecast from $85 to $94. Evercore ISI affirms an In-Line rating, with a modest increase in its price forecast from $77 to $80. Wells Fargo continues to maintain an Overweight rating, raising its price forecast from $80 to $84. Similarly, RBC Capital maintains an Outperform rating, lifting its price forecast from $85 to $89. Piper Sandler also keeps an Overweight rating, increasing its price target from $83 to $90. Barclays maintains an Overweight rating and has raised its price forecast from $90 to $95. Finally, a Stifel analyst has reiterated a Buy rating, also increasing the price forecast from $90 to $95. Price Action: EW stock is trading higher by 4.87% to $79.49 at last check Friday. Read Next:Image via Shutterstock Latest Ratings for EW Date Firm Action From To Feb 2022 UBS Upgrades Neutral Buy Jan 2022 Morgan Stanley Maintains Overweight Jan 2022 Raymond James Maintains Outperform View More Analyst Ratings for EW View the Latest Analyst Ratings UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? EDWARDS LIFESCIENCES (EW): Free Stock Analysis Report This article Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 minutes ago
- Yahoo
Why Advanced Micro Devices (AMD) Shares Are Climbing Today
Advanced Micro Devices (NASDAQ:AMD) shares climbed about 3% Friday after analysts flagged Intel's (NASDAQ:INTC) ongoing market?share losses to AMD. That's why investor confidence rose on expectations that AMD keeps grabbing business from its larger rival. Warning! GuruFocus has detected 5 Warning Signs with AMD. J.P. Morgan analysts noted Intel's shift toward a more fabless model won't pay off for another 1824 months, leaving AMD to reinforce its position with Ryzen and EPYC platforms. They see sustained momentum in AMD's server?CPU shipments as cloud providers and enterprises favor its cost?efficient designs. Morgan Stanley chimed in, pointing to Intel's margin pressures from startup costs and restructuring charges. That contrast boosts AMD's near?term outlook: its higher gross margins and leaner expense base paint a more resilient picture. Market watchers also highlight AMD's expanding GPU lineup as a secondary growth driver, with generative?AI workloads fueling demand alongside NVIDIA (NASDAQ:NVDA). As Intel grapples with transition costs, AMD stands to pick up share in both PC and data?center markets. With analysts' price targets generally above current levels, AMD's stock rally underscores a broader semiconductor shift, smaller players seizing ground as incumbents navigate costly transformations. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data